2021 Exhibitors, Industry CME Symposia, and Learning Theaters

Exhibitors, Industry Symposia, and Learning Theaters

Exhibitors

Visit the CHEST 2021 Online Exhibit Hall to learn about new products, technology, treatments, and more offered by exhibitors. Exhibitors will have their availability listed within their booths.

GOLD

Amgen/AstraZeneca
Amgen/AstraZeneca
Bayer
Boehringer Ingelheim Pharmaceuticals, Inc. – COPD
Boehringer Ingelheim Pharmaceuticals, Inc. – ILD
Gilead Sciences, Inc.
GlaxoSmithKline
GlaxoSmithKline Medical Affairs

Insmed Inc.
LivaNova
Natera, Inc.
Sanofi Genzyme and Regeneron
Sanofi Genzyme and Regeneron
Sanofi Genzyme and Regeneron
Sanofi Genzyme and Regeneron

SILVER

Fisher & Paykel Healthcare
Genentech USA, Inc.
Genentech USA, Inc.
Grifols USA, LLC

Intuitive Surgical Inc.
Veracyte, Inc.
VIATRIS | Theravance Biopharma, Inc.

BRONZE

Acceleron Pharma Inc.
Aerovate Therapeutics
Archbold Medical Center
AstraZeneca
Auris Health
BD
Bellerophon Therapeutics
Biodesix, Inc.
BioFire Diagnostics, LLC
Boston Scientific
BMS/Pfizer
Envision Physician Services
Erbe USA
European Respiratory Society
Fujifilm Medical Systems, U.S.A. Inc.
Fujifilm Sonosite
Inari Medical
Janssens Pharmaceuticals, Inc.

Jazz Pharmaceuticals
Mayne Pharma
Medtronic
Monaghan Medical Corporation
National Board of Echocardiography
Nuwellis, Inc.
Olympus America Inc.
Paratek Pharmaceuticals
Pulmonary Fibrosis Foundation
Pulmonx Corporation
SCP Health
Sound Physicians
TeamHealth
United Therapeutics
US Acute Care Solutions
Vapotherm Access
VitalFlo Health

Industry Supported CME Satellite Symposia

Only CHEST Annual Meeting 2021 registered attendees will be able to access and attend the Industry Supported CME Satellite Symposia.*

11:45 am – 12:45 pm CT

A New Paradigm in Treating ILD
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.


Chronic Cough: Novel Therapies on the Horizon to Reduce Burden and Improve Quality of Life
This continuing medical education activity is provided by Vindico Medical Education.
This activity is supported by an educational grant from Merck & Co., Inc.


Guideline-Endorsed Answers to Key Questions in Nontuberculous Mycobacterial Lung Disease Management
Provided by Clinical Care Options, LLC.
Supported by an educational grant from Insmed.


Holding Court in PH: When Considering Escalation of Treatment, Does Delay in Escalation Beyond 3 Months Worsen Overall Prognosis?
Jointly provided by TotalCME and Postgraduate Institute for Medicine.
Supported by educational grants from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson and United Therapeutics Corporation.

5:15 pm – 6:15 pm CT

Alpha-1 Antitrypsin Deficiency – Strategies to Optimize Screening, Diagnosis, and Management
Provided by Physicians’ Education Resource, LLC.
This activity is supported by educational grants from Grifols and Takeda Pharmaceuticals U.S.A, Inc.


Cases and Considerations in PAH: From Diagnosis to Effective Treatment
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Supported by an independent educational grant from Actelion, Bayer, Merck, and United Therapeutics.


Practical Solutions to Real World Challenges in SSc-ILD Treatment
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.


The IPF Disease Challenge
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.


Where Are the New Targets in Severe Asthma? Looking Upstream in the Inflammatory Cascade
This educational activity is provided by National Jewish Health. National Jewish Health is accredited by the Accreditation Council of Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This educational activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

6:30 am – 7:30 am CT

Breathtaking Updates in Functional Lung Testing and Imaging
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Supported by an independent educational grant from Polarean Imaging.


Novel Therapeutic Options for the Management of Pulmonary Hypertension Due to Interstitial Lung Disease
This continuing medical education activity is provided by Vindico Medical Education.
This activity is supported by an educational grant from United Therapeutics Corporation.


Targeted Management of Asthma: Using Phenotypes and Biomarkers to Individualize Treatment
This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.

6:30 am – 7:30 am CT

A Collaborative Approach to IPF Management
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.


What Can You Do to Improve Clinical Outcomes for Your Patients With Viral Influenza at High Risk for Pulmonary Complications?
This activity is provided by Med Learning Group.
Supported by an educational grant from Genentech, a member of the Roche Group.

6:30 am – 7:30 am CT

Post COVID-19 and Patients With and Without Pre-existing ILD
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

5:00 pm – 6:00 pm CT

Exploring the Potential for Risk Reduction and Right Heart Reverse Remodeling in PAH: A Focus on Upfront Combination Therapy
This activity is provided by Integrity Continuing Education, Inc.
This activity has been supported by an educational grant by Actelion Pharmaceuticals US Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.

Learning Theaters

Learning Theater presentations* offer CHEST 2021 attendees an opportunity hear about specific disease states, new treatments, and technologies in a virtual theater setting.

12:20 pm – 1:05 pm CT

Advancements in VTE Prophylaxis of Acutely Ill Medical Patients and Treatment of DVT/PE
Sponsored by Janssen Pharmaceuticals, Inc.


Exploring OFEV® (Nintedanib) Capsules: A Treatment Journey
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.


Targeting Systemic and Localized Type 2 Inflammation in Asthma
Sponsored by Sanofi Genzyme and Regeneron


The Journey Towards Controlled Asthma – One Step at a Time
Sponsored by GlaxoSmithKline


Treating Community-Acquired Bacterial Pneumonia (CABP): Use of Xenleta® (lefamulin)
Sponsored by Nabriva Therapeutics US, Inc.

5:45 pm – 6:30 pm CT

Alpha-1 Antitrypsin Deficiency: Overview, Diagnosis, and a Treatment Option
Sponsored by Takeda Pharmaceuticals


Clinical Utility of a Blood-based Biomarker Test Designed to Reduce Invasive Procedures on Benign Lung Nodules: Institutional Experience From Investigators Participating in the ORACLE Clinical Registry Study
Sponsored by Biodesix, Inc.


Comparative Effectiveness of Oral Prostacyclin Pathway Drugs on Hospitalization in US PH Patients: Findings From a Retrospective Database Analysis
Sponsored by Janssen, A Pharmaceutical Company of Johnson & Johnson


Tackling Diverse and Challenging Clinical Profiles Across the Asthma Endo/Phenotypic Spectrum
Sponsored by GlaxoSmithKline


Zephyr Endobronchial Valves for the Treatment of Severe Emphysema: Patient Referral Guidelines and Procedural State of the Art
Sponsored by Pulmonx Corporation

12:30 pm – 1:15 pm CT

Clinical Evidence for the Selection of Triple Therapy Maintenance Treatment for Adult Patients With COPD or Asthma
Sponsored by GlaxoSmithKline


Evolving Data Through a Multi-center, Noninferiority, Randomized Clinical Trial in Lung Transplant, Leveraging Donor-derived, Cell-free DNA Monitoring
Sponsored by Natera, Inc.


Focus on Type 2 Inflammation in Certain Diseases, Including Eosinophilic Esophagitis
Sponsored by Sanofi Genzyme and Regeneron


Initiating LAMA/LABA Therapy in Patients With COPD: Current Insights on How Patient Symptoms, Ability, and Preference Should Guide Treatment
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.


The COVID-19 Pandemic and a Treatment Approach
Sponsored by Gilead Sciences, Inc.

1:30 pm – 2:15 pm CT

A New Era in the COVID-19 Pandemic: Early Disease Management in a Time of Variants and Vaccination Event
Sponsored by GlaxoSmithKline


An Effective, Broad-Spectrum Antibiotic for the Treatment of CABP in Adults
Sponsored by Paratek Pharmaceuticals


Exploring the Role of OFEV® (nintedanib) Capsules
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.


Lung Cancer and the COVID-19 Pandemic: Working Together to Optimize Continuation of Care
Sponsored by AstraZeneca


Novel Genomic Testing: Addressing Disparity in Lung Cancer Risk Assessment, Diagnosis, and Treatment Management
Sponsored by Veracyte, Inc.

12:35 pm – 1:20 pm CT

AlloSure Lung: A Noninvasive Solution for Lung Transplant Surveillance
Sponsored by CareDx, Inc.


Evidence for Using a Biologic to Treat Two Different Eosinophil-Driven Diseases: Severe Eosinophilic Asthma and Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Sponsored by GlaxoSmithKline


The Clinical Utility of the BioFire® FilmArray® Pneumonia Panel and Procalcitonin to Aid in Pneumonia Diagnosis
Sponsored by BioFire Diagnostics, LLC


The Interventional Treatment of PE: Expanding the Clinical Evidence Base With HI-PEITHO and KNOCOUT PE
Sponsored by Boston Scientific

1:35 pm – 2:20 pm CT

Recognizing the Rare: Diseases of Hypereosinophilia
Sponsored by GlaxoSmithKline


Robotic Bronchoscopy – Experienced User Case Review for Biopsying Small Nodules
Sponsored by Intuitive Surgical, Inc.

PRECISION: Using Evidence-based Tools to Help Advance the Identification and Management of Uncontrolled Asthma
Sponsored by AstraZeneca


TSLP in Asthma: Examining the Evidence
Sponsored by Amgen/AstraZeneca

Non-CME Satellite Symposium

Only CHEST Annual Meeting 2021 registered attendees will be able to access and attend the Industry Sponsored Non-CME Satellite Symposium.*

6 – 7 pm CT

Autoimmune-Associated Interstitial Lung Disease: An Overview of Interstitial Lung Disease and Patient Cases
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

*These symposia and learning theater presentations are not supported, endorsed, or accredited by the American College of Chest Physicians.

CHEST 2021 sponsors

CHEST thanks the following sponsors for their support!

Amgen/AstraZeneca
AstraZeneca
Biodesix, Inc.
BioFire Diagnostics, LLC
Boehringer Ingelheim Pharmaceuticals, Inc.
Boston Scientific
CareDx, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Janssen, A Pharmaceutical Company of Johnson & Johnson
Paratek Pharmaceuticals
Pulmonx Corporation
Sanofi Genzyme and Regeneron
Veracyte, Inc.
Viatris, Inc.
Janssen, A Pharmaceutical Company of Johnson & Johnson
Janssen Pharmaceuticals, Inc.
Nabriva Therapeutics US, Inc.
Natera, Inc.
Paratek Pharmaceuticals
Pulmonx Corporation
Sanofi Genzyme andRegeneron
Takeda Pharmaceuticals
Veracyte, Inc.